Categories: Combinationtreatment

Combination treatment for methamphetamine use disorder shows promise in new study

A combination of two medications, injectable naltrexone and oral bupropion, was safe and effective in treating adults with severe or moderate methamphetamine use disorder in a double, placebo-controlled Phase III clinical trial. The findings suggest this combination therapy might be a promising addition to present approaches to treatment, such as cognitive behavioral treatment and contingency management interventions, for a very serious illness that remains hard to treat and conquer. The study, published today in The New England Journal of Medicine, has been conducted in multiple sites within the National Institute on Drug Abuse Clinical Trials Network (NIDA CTN). NIDA is part of the National Institutes of Health.
Read More

News Bot

Published by
News Bot

Recent Posts

A look whatsoever of Biden’s modifications to energy and environmental regulations

There's a lot going on in addition to some of Biden's high-profile moves.

39 mins ago

Resident Evil VIII has May launch date, enormous preview, playable demo

A free no-combat demo goes live on PlayStation 5 today; will hit Xbox, PC later.

39 mins ago

“Complete incompetence:” Biden team slams Trump’s COVID job

Biden Administration starts off with a flurry of orders, actions, and comprehensive plan.

39 mins ago

Parler’s attempt to get back on Amazon Web Services refused by estimate

Judge denies injunction motion, says Parler's claims against Amazon are weak.

39 mins ago

Google agrees to pay French news sites to send traffic

The French agreement could become a template for similar deals across Europe.

39 mins ago

An Advertisement agency sued Omnicom’s DDB, alleging it Had Been’exploited’ to win a $4 billion US Army contract

Summary List PlacementNew York ad agency Hero Group sued Omnicom-owned agency DDB in federal court…

43 mins ago